IBDEI029 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2443,1,5,0)
 ;;=5^LONG-TERM USE OF ASPIRIN
 ;;^UTILITY(U,$J,358.3,2443,2)
 ;;=^331584
 ;;^UTILITY(U,$J,358.3,2444,0)
 ;;=V58.67^^23^206^24
 ;;^UTILITY(U,$J,358.3,2444,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2444,1,2,0)
 ;;=2^V58.67
 ;;^UTILITY(U,$J,358.3,2444,1,5,0)
 ;;=5^LONG-TERM USE OF INSULIN
 ;;^UTILITY(U,$J,358.3,2444,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,2445,0)
 ;;=V58.69^^23^206^18
 ;;^UTILITY(U,$J,358.3,2445,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2445,1,2,0)
 ;;=2^V58.69
 ;;^UTILITY(U,$J,358.3,2445,1,5,0)
 ;;=5^L/T (CURRENT) USE - OTH MEDS
 ;;^UTILITY(U,$J,358.3,2445,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,2446,0)
 ;;=V65.40^^23^206^29
 ;;^UTILITY(U,$J,358.3,2446,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2446,1,2,0)
 ;;=2^V65.40
 ;;^UTILITY(U,$J,358.3,2446,1,5,0)
 ;;=5^OTH UNSP COUNSEL NOC
 ;;^UTILITY(U,$J,358.3,2446,2)
 ;;=^87449
 ;;^UTILITY(U,$J,358.3,2447,0)
 ;;=V65.41^^23^206^9
 ;;^UTILITY(U,$J,358.3,2447,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2447,1,2,0)
 ;;=2^V65.41
 ;;^UTILITY(U,$J,358.3,2447,1,5,0)
 ;;=5^EXERCISE COUNSELING
 ;;^UTILITY(U,$J,358.3,2447,2)
 ;;=^303466
 ;;^UTILITY(U,$J,358.3,2448,0)
 ;;=V65.43^^23^206^4
 ;;^UTILITY(U,$J,358.3,2448,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2448,1,2,0)
 ;;=2^V65.43
 ;;^UTILITY(U,$J,358.3,2448,1,5,0)
 ;;=5^COUNSEL-INJURY PREVEN
 ;;^UTILITY(U,$J,358.3,2448,2)
 ;;=^303468
 ;;^UTILITY(U,$J,358.3,2449,0)
 ;;=V65.45^^23^206^5
 ;;^UTILITY(U,$J,358.3,2449,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2449,1,2,0)
 ;;=2^V65.45
 ;;^UTILITY(U,$J,358.3,2449,1,5,0)
 ;;=5^COUNSEL-OTH SEX TX DISEASES
 ;;^UTILITY(U,$J,358.3,2449,2)
 ;;=^303470
 ;;^UTILITY(U,$J,358.3,2450,0)
 ;;=V71.09^^23^207^1
 ;;^UTILITY(U,$J,358.3,2450,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2450,1,2,0)
 ;;=2^V71.09
 ;;^UTILITY(U,$J,358.3,2450,1,5,0)
 ;;=5^OBSERV-MENTAL COND NEC
 ;;^UTILITY(U,$J,358.3,2450,2)
 ;;=^295604
 ;;^UTILITY(U,$J,358.3,2451,0)
 ;;=99080^^24^208^7^^^^1
 ;;^UTILITY(U,$J,358.3,2451,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2451,1,2,0)
 ;;=2^99080
 ;;^UTILITY(U,$J,358.3,2451,1,3,0)
 ;;=3^SPECIAL REPORTS OR FORMS
 ;;^UTILITY(U,$J,358.3,2452,0)
 ;;=97535^^24^208^6^^^^1
 ;;^UTILITY(U,$J,358.3,2452,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2452,1,2,0)
 ;;=2^97535
 ;;^UTILITY(U,$J,358.3,2452,1,3,0)
 ;;=3^SELF CARE MNGMENT TRAINING
 ;;^UTILITY(U,$J,358.3,2453,0)
 ;;=99366^^24^208^8^^^^1
 ;;^UTILITY(U,$J,358.3,2453,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2453,1,2,0)
 ;;=2^99366
 ;;^UTILITY(U,$J,358.3,2453,1,3,0)
 ;;=3^TEAM CONF W/PAT BY HC PRO
 ;;^UTILITY(U,$J,358.3,2454,0)
 ;;=A9279^^24^208^5^^^^1
 ;;^UTILITY(U,$J,358.3,2454,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2454,1,2,0)
 ;;=2^A9279
 ;;^UTILITY(U,$J,358.3,2454,1,3,0)
 ;;=3^MONITORING FEATURE/DEVICE NOC
 ;;^UTILITY(U,$J,358.3,2455,0)
 ;;=H0034^^24^208^4^^^^1
 ;;^UTILITY(U,$J,358.3,2455,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2455,1,2,0)
 ;;=2^H0034
 ;;^UTILITY(U,$J,358.3,2455,1,3,0)
 ;;=3^MED TRNG & SUPPORT PER 15MIN
 ;;^UTILITY(U,$J,358.3,2456,0)
 ;;=S9455^^24^208^1^^^^1
 ;;^UTILITY(U,$J,358.3,2456,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2456,1,2,0)
 ;;=2^S9455
 ;;^UTILITY(U,$J,358.3,2456,1,3,0)
 ;;=3^DIAB MANAGE TRN GROUP
 ;;^UTILITY(U,$J,358.3,2457,0)
 ;;=S9445^^24^208^2^^^^1
 ;;^UTILITY(U,$J,358.3,2457,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2457,1,2,0)
 ;;=2^S9445
 ;;^UTILITY(U,$J,358.3,2457,1,3,0)
 ;;=3^DIAB MANAGE TRN PER INDIV
 ;;^UTILITY(U,$J,358.3,2458,0)
 ;;=S9446^^24^208^3^^^^1
 ;;^UTILITY(U,$J,358.3,2458,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2458,1,2,0)
 ;;=2^S9446
 ;;^UTILITY(U,$J,358.3,2458,1,3,0)
 ;;=3^GROUP HEALTH EDUCATION
 ;;^UTILITY(U,$J,358.3,2459,0)
 ;;=S9445^^24^209^1^^^^1
 ;;^UTILITY(U,$J,358.3,2459,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2459,1,2,0)
 ;;=2^S9445
 ;;^UTILITY(U,$J,358.3,2459,1,3,0)
 ;;=3^PT EDUCATION NOC INDIVID
 ;;^UTILITY(U,$J,358.3,2460,0)
 ;;=99091^^24^210^1^^^^1
 ;;^UTILITY(U,$J,358.3,2460,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2460,1,2,0)
 ;;=2^99091
 ;;^UTILITY(U,$J,358.3,2460,1,3,0)
 ;;=3^COLLECT/REVIEW DATA FROM PT
 ;;^UTILITY(U,$J,358.3,2461,0)
 ;;=G0155^^24^211^1^^^^1
 ;;^UTILITY(U,$J,358.3,2461,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2461,1,2,0)
 ;;=2^G0155
 ;;^UTILITY(U,$J,358.3,2461,1,3,0)
 ;;=3^HOME VISIT BY CSW,EA 15 MIN
 ;;^UTILITY(U,$J,358.3,2462,0)
 ;;=90847^^24^212^1^^^^1
 ;;^UTILITY(U,$J,358.3,2462,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2462,1,2,0)
 ;;=2^90847
 ;;^UTILITY(U,$J,358.3,2462,1,3,0)
 ;;=3^FAMILY PSYTX W/PATIENT
 ;;^UTILITY(U,$J,358.3,2463,0)
 ;;=90849^^24^212^3^^^^1
 ;;^UTILITY(U,$J,358.3,2463,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2463,1,2,0)
 ;;=2^90849
 ;;^UTILITY(U,$J,358.3,2463,1,3,0)
 ;;=3^MULTIPLE FAMILY GROUP PSYTX
 ;;^UTILITY(U,$J,358.3,2464,0)
 ;;=90853^^24^212^2^^^^1
 ;;^UTILITY(U,$J,358.3,2464,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2464,1,2,0)
 ;;=2^90853
 ;;^UTILITY(U,$J,358.3,2464,1,3,0)
 ;;=3^GROUP PSYCHOTHERAPY
 ;;^UTILITY(U,$J,358.3,2465,0)
 ;;=90832^^24^212^4^^^^1
 ;;^UTILITY(U,$J,358.3,2465,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2465,1,2,0)
 ;;=2^90832
 ;;^UTILITY(U,$J,358.3,2465,1,3,0)
 ;;=3^PSYTX PT OR FAMILY 17-32 MIN
 ;;^UTILITY(U,$J,358.3,2466,0)
 ;;=90834^^24^212^5^^^^1
 ;;^UTILITY(U,$J,358.3,2466,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2466,1,2,0)
 ;;=2^90834
 ;;^UTILITY(U,$J,358.3,2466,1,3,0)
 ;;=3^PSYTX PT OR FAMILY 38-52 MIN
 ;;^UTILITY(U,$J,358.3,2467,0)
 ;;=90837^^24^212^6^^^^1
 ;;^UTILITY(U,$J,358.3,2467,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2467,1,2,0)
 ;;=2^90837
 ;;^UTILITY(U,$J,358.3,2467,1,3,0)
 ;;=3^PSYTX PT OR FAMILY 53+ MIN
 ;;^UTILITY(U,$J,358.3,2468,0)
 ;;=T1016^^24^213^1^^^^1
 ;;^UTILITY(U,$J,358.3,2468,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2468,1,2,0)
 ;;=2^T1016
 ;;^UTILITY(U,$J,358.3,2468,1,3,0)
 ;;=3^CASE MANAGEMENT EA 15MIN
 ;;^UTILITY(U,$J,358.3,2469,0)
 ;;=V71.89^^25^214^1
 ;;^UTILITY(U,$J,358.3,2469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2469,1,3,0)
 ;;=3^ENROLLMENT IN CCHT PROGRAM
 ;;^UTILITY(U,$J,358.3,2469,1,4,0)
 ;;=4^V71.89
 ;;^UTILITY(U,$J,358.3,2469,2)
 ;;=^322082
 ;;^UTILITY(U,$J,358.3,2470,0)
 ;;=441.4^^26^215^1
 ;;^UTILITY(U,$J,358.3,2470,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2470,1,2,0)
 ;;=2^441.4
 ;;^UTILITY(U,$J,358.3,2470,1,5,0)
 ;;=5^ABDOM AORTIC ANEURYSM
 ;;^UTILITY(U,$J,358.3,2470,2)
 ;;=^269769
 ;;^UTILITY(U,$J,358.3,2471,0)
 ;;=995.3^^26^215^2
 ;;^UTILITY(U,$J,358.3,2471,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2471,1,2,0)
 ;;=2^995.3
 ;;^UTILITY(U,$J,358.3,2471,1,5,0)
 ;;=5^ALLERGIC REACTION
 ;;^UTILITY(U,$J,358.3,2471,2)
 ;;=^60275
 ;;^UTILITY(U,$J,358.3,2472,0)
 ;;=477.9^^26^215^3
 ;;^UTILITY(U,$J,358.3,2472,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2472,1,2,0)
 ;;=2^477.9
 ;;^UTILITY(U,$J,358.3,2472,1,5,0)
 ;;=5^ALLERGIC RHINITIS NOS
 ;;^UTILITY(U,$J,358.3,2472,2)
 ;;=^4955
 ;;^UTILITY(U,$J,358.3,2473,0)
 ;;=331.0^^26^215^4
 ;;^UTILITY(U,$J,358.3,2473,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2473,1,2,0)
 ;;=2^331.0
 ;;^UTILITY(U,$J,358.3,2473,1,5,0)
 ;;=5^ALZHEIMER'S DISEASE
 ;;^UTILITY(U,$J,358.3,2473,2)
 ;;=^5679
 ;;^UTILITY(U,$J,358.3,2474,0)
 ;;=280.9^^26^215^6
 ;;^UTILITY(U,$J,358.3,2474,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2474,1,2,0)
 ;;=2^280.9
 ;;^UTILITY(U,$J,358.3,2474,1,5,0)
 ;;=5^ANEMIA,IRON DEFIC
 ;;^UTILITY(U,$J,358.3,2474,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,2475,0)
 ;;=285.9^^26^215^5
 ;;^UTILITY(U,$J,358.3,2475,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2475,1,2,0)
 ;;=2^285.9
 ;;^UTILITY(U,$J,358.3,2475,1,5,0)
 ;;=5^ANEMIA NOS
 ;;^UTILITY(U,$J,358.3,2475,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,2476,0)
 ;;=413.9^^26^215^7
 ;;^UTILITY(U,$J,358.3,2476,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2476,1,2,0)
 ;;=2^413.9
 ;;^UTILITY(U,$J,358.3,2476,1,5,0)
 ;;=5^ANGINA
 ;;^UTILITY(U,$J,358.3,2476,2)
 ;;=^87258
 ;;^UTILITY(U,$J,358.3,2477,0)
 ;;=424.1^^26^215^8
 ;;^UTILITY(U,$J,358.3,2477,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2477,1,2,0)
 ;;=2^424.1
 ;;^UTILITY(U,$J,358.3,2477,1,5,0)
 ;;=5^AORTIC STENOSIS
 ;;^UTILITY(U,$J,358.3,2477,2)
 ;;=^9330
 ;;^UTILITY(U,$J,358.3,2478,0)
 ;;=716.90^^26^215^9
 ;;^UTILITY(U,$J,358.3,2478,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2478,1,2,0)
 ;;=2^716.90
 ;;^UTILITY(U,$J,358.3,2478,1,5,0)
 ;;=5^ARTHRITIS NOS
 ;;^UTILITY(U,$J,358.3,2478,2)
 ;;=^66343
 ;;^UTILITY(U,$J,358.3,2479,0)
 ;;=493.90^^26^215^10
 ;;^UTILITY(U,$J,358.3,2479,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2479,1,2,0)
 ;;=2^493.90
 ;;^UTILITY(U,$J,358.3,2479,1,5,0)
 ;;=5^ASTHMA NOS
 ;;^UTILITY(U,$J,358.3,2479,2)
 ;;=^330091
 ;;^UTILITY(U,$J,358.3,2480,0)
 ;;=427.31^^26^215^11
 ;;^UTILITY(U,$J,358.3,2480,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2480,1,2,0)
 ;;=2^427.31
 ;;^UTILITY(U,$J,358.3,2480,1,5,0)
 ;;=5^ATRIAL FIBRILLATION
 ;;^UTILITY(U,$J,358.3,2480,2)
 ;;=^11378
 ;;^UTILITY(U,$J,358.3,2481,0)
 ;;=427.32^^26^215^12
 ;;^UTILITY(U,$J,358.3,2481,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2481,1,2,0)
 ;;=2^427.32
 ;;^UTILITY(U,$J,358.3,2481,1,5,0)
 ;;=5^ATRIAL FLUTTER
 ;;^UTILITY(U,$J,358.3,2481,2)
 ;;=^11387
 ;;^UTILITY(U,$J,358.3,2482,0)
 ;;=266.2^^26^216^1
 ;;^UTILITY(U,$J,358.3,2482,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2482,1,2,0)
 ;;=2^266.2
 ;;^UTILITY(U,$J,358.3,2482,1,5,0)
 ;;=5^B-12 DEFICIENCY
 ;;^UTILITY(U,$J,358.3,2482,2)
 ;;=^87347
 ;;^UTILITY(U,$J,358.3,2483,0)
 ;;=600.00^^26^216^5
 ;;^UTILITY(U,$J,358.3,2483,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2483,1,2,0)
 ;;=2^600.00
 ;;^UTILITY(U,$J,358.3,2483,1,5,0)
 ;;=5^BPH W/O URINARY OBSTRUCT
 ;;^UTILITY(U,$J,358.3,2483,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,2484,0)
 ;;=600.01^^26^216^4
 ;;^UTILITY(U,$J,358.3,2484,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2484,1,2,0)
 ;;=2^600.01
